Evaluation of hybrid care paths with Home Blood Pressure Telemonitoring through a quintiple aim perspective (clinical efficiency, cost-effectiveness, healthcare provider experience, patient experience and health equity).
My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
We aim to identify, develop, and implement Health-IT solutions that improve prescribing.
Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.